- Home
- CGON vs IREN Comparison
CGON vs IREN Comparison
Compare CGON & IREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- IREN
- Stock Information
- Founded
- CGON 2010
- IREN 2018
- Country
- CGON United States
- IREN Australia
- Employees
- CGON N/A
- IREN N/A
- Industry
- CGON
- IREN EDP Services
- Sector
- CGON
- IREN Technology
- Exchange
- CGON NYSE
- IREN Nasdaq
- Market Cap
- CGON 1.3B
- IREN 1.4B
- IPO Year
- CGON 2024
- IREN 2021
- Fundamental
- Price
- CGON $20.64
- IREN $5.59
- Analyst Decision
- CGON Strong Buy
- IREN Strong Buy
- Analyst Count
- CGON 10
- IREN 11
- Target Price
- CGON $65.11
- IREN $19.30
- AVG Volume (30 Days)
- CGON 1.3M
- IREN 13.6M
- Earning Date
- CGON 05-08-2025
- IREN 05-14-2025
- Dividend Yield
- CGON N/A
- IREN N/A
- EPS Growth
- CGON N/A
- IREN N/A
- EPS
- CGON N/A
- IREN N/A
- Revenue
- CGON $1,139,000.00
- IREN $285,765,000.00
- Revenue This Year
- CGON N/A
- IREN $183.61
- Revenue Next Year
- CGON $16,237.24
- IREN $80.31
- P/E Ratio
- CGON N/A
- IREN N/A
- Revenue Growth
- CGON 461.08
- IREN 133.25
- 52 Week Low
- CGON $14.80
- IREN $4.15
- 52 Week High
- CGON $46.99
- IREN $15.92
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- IREN 38.67
- Support Level
- CGON $19.47
- IREN $5.24
- Resistance Level
- CGON $20.63
- IREN $5.93
- Average True Range (ATR)
- CGON 2.07
- IREN 0.60
- MACD
- CGON 0.20
- IREN 0.07
- Stochastic Oscillator
- CGON 48.59
- IREN 28.10
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About IREN Iris Energy Limited
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.